• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Left ventricular myocardial fibrosis: a marker of bad prognosis in symptomatic severe aortic stenosis.

作者信息

Kong William K F, Bax Jeroen J, Delgado Victoria

机构信息

Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.

Department of Cardiology, National University Heart Centre, National University Health System, Singapore.

出版信息

Eur Heart J. 2020 May 21;41(20):1915-1917. doi: 10.1093/eurheartj/ehaa151.

DOI:10.1093/eurheartj/ehaa151
PMID:32211751
Abstract
摘要

相似文献

1
Left ventricular myocardial fibrosis: a marker of bad prognosis in symptomatic severe aortic stenosis.左心室心肌纤维化：有症状的重度主动脉瓣狭窄患者预后不良的一个标志物。
Eur Heart J. 2020 May 21;41(20):1915-1917. doi: 10.1093/eurheartj/ehaa151.
2
Prognostic value of myocardial fibrosis in severe aortic stenosis: study protocol for a prospective observational multi-center study (FIB-AS).心肌纤维化对严重主动脉瓣狭窄的预后价值：前瞻性观察性多中心研究（FIB-AS）方案。
BMC Cardiovasc Disord. 2020 Jun 8;20(1):275. doi: 10.1186/s12872-020-01552-8.
3
Postoperative Reverse Remodeling and Symptomatic Improvement in Normal-Flow Low-Gradient Aortic Stenosis After Aortic Valve Replacement.主动脉瓣置换术后正常血流低梯度主动脉瓣狭窄患者的术后逆向重构及症状改善
Circ Cardiovasc Imaging. 2017 Dec;10(12). doi: 10.1161/CIRCIMAGING.117.006580.
4
The impact of age on the postoperative response of the diastolic function and left ventricular mass regression after surgical or transcatheter aortic valve replacement for severe aortic stenosis.年龄对严重主动脉瓣狭窄患者接受外科手术或经导管主动脉瓣置换术后舒张功能和左心室质量消退的术后反应的影响。
Surg Today. 2017 Jun;47(6):770-776. doi: 10.1007/s00595-016-1458-6. Epub 2016 Dec 24.
5
Association of Acylcarnitines With Left Ventricular Remodeling in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术治疗重度主动脉瓣狭窄患者的酰基辅酶 A 与左心室重构的关系。
JAMA Cardiol. 2018 Mar 1;3(3):242-246. doi: 10.1001/jamacardio.2017.4873.
6
Predictive Value of Left Ventricular Myocardial Deformation for Left Ventricular Remodeling in Patients With Classical Low-Flow, Low-Gradient Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术治疗经典低流量、低梯度主动脉瓣狭窄患者左心室心肌变形对左心室重构的预测价值。
J Am Soc Echocardiogr. 2019 Jun;32(6):730-736. doi: 10.1016/j.echo.2019.03.002.
7
Relative Contribution of Afterload and Interstitial Fibrosis to Myocardial Function in Severe Aortic Stenosis.严重主动脉瓣狭窄患者心肌功能的后负荷和细胞外间质纤维化的相对贡献
JACC Cardiovasc Imaging. 2020 Feb;13(2 Pt 2):589-600. doi: 10.1016/j.jcmg.2019.05.020. Epub 2019 Jul 17.
8
Myocardial Scar and Mortality in Severe Aortic Stenosis.严重主动脉瓣狭窄的心肌瘢痕与死亡率。
Circulation. 2018 Oct 30;138(18):1935-1947. doi: 10.1161/CIRCULATIONAHA.117.032839.
9
Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis.心肌纤维化对严重主动脉瓣狭窄患者的预后价值。
J Thorac Cardiovasc Surg. 2012 Oct;144(4):830-7. doi: 10.1016/j.jtcvs.2011.11.024. Epub 2012 Jan 12.
10
Left ventricular hypertrophy in valvular aortic stenosis: mechanisms and clinical implications.瓣膜性主动脉瓣狭窄中的左心室肥厚：机制及临床意义
Am J Med. 2015 Apr;128(4):344-52. doi: 10.1016/j.amjmed.2014.10.054. Epub 2014 Nov 25.

引用本文的文献

1
Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED Randomized Clinical Trial.无症状严重主动脉瓣狭窄和心肌纤维化患者的早期干预：EVOLVED随机临床试验
JAMA. 2025 Jan 21;333(3):213-221. doi: 10.1001/jama.2024.22730.
2
Natural history of initially asymptomatic severe aortic stenosis: a one-stage meta-analysis.初发无症状重度主动脉瓣狭窄的自然病史：一项单阶段荟萃分析
Clin Res Cardiol. 2025 Mar;114(3):350-367. doi: 10.1007/s00392-024-02465-8. Epub 2024 Jul 15.
3
Glasgow Prognostic Score as a Marker of Mortality after TAVI.
经 TAVI 治疗后，格拉斯哥预后评分作为死亡率的标志物。
Braz J Cardiovasc Surg. 2021 Dec 3;36(6):796-801. doi: 10.21470/1678-9741-2020-0269.
4
Antifibrotic Effect of a Novel Selective 11β-HSD2 Inhibitor (WZ51) in a rat Model of Myocardial Fibrosis.新型选择性11β-羟基类固醇脱氢酶2抑制剂（WZ51）在大鼠心肌纤维化模型中的抗纤维化作用
Front Pharmacol. 2021 Mar 22;12:629818. doi: 10.3389/fphar.2021.629818. eCollection 2021.